Nu Skin Enterprises (NYSE:NUS) Updates FY 2025 Earnings Guidance

Nu Skin Enterprises (NYSE:NUS) updated its FY 2025 earnings guidance on Thursday. The company provided earnings per share guidance of 0.900-1.300 for the period, compared to the consensus earnings per share estimate of 0.760. The company issued revenue guidance of $1.5 billion-$1.6 billion, compared to the consensus revenue estimate of $1.7 billion. Nu Skin Enterprises also updated its Q1 2025 guidance to 0.100-0.200 EPS.

Nu Skin Enterprises Stock Performance

Shares of Nu Skin Enterprises stock traded up $0.09 during midday trading on Thursday, hitting $6.41. The company had a trading volume of 1,299,428 shares, compared to its average volume of 687,522. The business’s 50 day simple moving average is $6.91 and its two-hundred day simple moving average is $7.50. The stock has a market cap of $318.40 million, a PE ratio of -3.09 and a beta of 1.17. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.93 and a quick ratio of 1.20. Nu Skin Enterprises has a 1-year low of $5.95 and a 1-year high of $17.68.

Nu Skin Enterprises (NYSE:NUS) last announced its quarterly earnings data on Thursday, February 13th. The company reported $0.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.24 by $0.14. Nu Skin Enterprises had a negative net margin of 5.81% and a positive return on equity of 5.47%. As a group, equities analysts predict that Nu Skin Enterprises will post 0.68 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

NUS has been the topic of several research analyst reports. DA Davidson lowered their price objective on shares of Nu Skin Enterprises from $11.00 to $7.00 and set a “neutral” rating on the stock in a research note on Friday, December 20th. StockNews.com upgraded shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research note on Monday, November 11th. Finally, Citigroup lowered their price objective on shares of Nu Skin Enterprises from $11.50 to $6.75 and set a “neutral” rating on the stock in a research note on Tuesday, October 22nd.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.